Compound atlas
Anti-aging

Vesugen

Bioregulator
Half-life
0.5h
approx. mean t½
Dose range
1–5 mg / cycle
typical, not prescriptive
Category
Anti-aging
primary use-case
Single-dose decay
t½ = 30m · first-order model
~2h
to clear
1× t½
50%
remaining
2× t½
25%
remaining
~4× t½
6%
remaining
0%25%50%75%100%0m1.2h2.4h3.6h4.8h6h

How a single dose clears, assuming first-order elimination. The half-life is the biggest driver of how often you dose — start a cycle to see your own cumulative concentration curve.

Overview

A peptide bioregulator (Khavinson) targeting vascular (blood-vessel) tissue.

Mechanism of action

Proposed vascular-tissue bioregulation supporting endothelial function.

Typical protocol

1–5 mg subQ over 5–10 day cycles.

Storage

Reconstituted: refrigerated, ~30 days.

Disclaimer

This page summarizes publicly available information. None of it constitutes medical advice, prescription, or recommendation to acquire, possess, or use any compound. Many peptides described are research chemicals not approved for human use in the EU. Consult a licensed physician.